Cancer - Sarcoma - Clinical Trial Testing a Vaccine for Sarcoma
Summary
This is a clinical trial for individuals who have recently been diagnosed with metastatic sarcoma (Stage IV) or who were previously diagnosed, recently underwent surgery, and are now disease free.
Therapeutic Area
Cancer - Sarcoma
Age Range
16 to no upper age limit
Purpose
The primary purpose of this trial is to test a novel vaccine designed to instruct the immune system to destroy any sarcoma cells that remain in the body after surgery compared to non-specific immune therapy.
The vaccine is given as an outpatient treatment with the goal of preventing or delaying sarcoma recurrence.
Who is Eligible?
To participate you must:
Have mestastatic sarcoma that can or already has been be completely removed by surgery and receive your first dose of investigational vaccine within 8 weeks of surgery.
Who is Not Eligible?
You are not eligible if you:
Are not disease free at the time of vaccination
A study physician will discuss other exclusions with you.
